The Cullen Eduction and Research Fund has decided to promote research into aspects of muscle atrophy and loss of functionality associated with motor neuron disease / amyotrophic lateral sclerosis (MND/ALS) with a prestigious award and a prize of €1M.
The €1 Million Cullen Education and Research Fund Prize aims to facilitate a more normal lifestyle for people with MND/ALS while – ideally – extending life expectancy.
The judging panel will consider any solution that gives an MND/ALS patient independence and allows them to breathe, walk, talk, lift a coffee, drive a car and otherwise operate independently. The CERF prize will catalyze development of new approaches to preserve or improve function by any means, including – but not limited to – biological, chemical, mechanical or electrical.
Motor Neuron Disease, also known as Amyotrophic Lateral Sclerosis (ALS) is a global disease in which an affected person loses muscle strength, which leads, in turn, to reduced function.
- September 30th 2020 – The deadline for registering your intent to compete
- 31st December 2020 – Full Submission Deadline
Read more on https://www.cerfprize.com/
Inquiries can be sent to email@example.com